Pfizer Inc. buy Guggenheim
Start price
18.03.25
/
50%
€24.09
Target price
18.03.26
-
Performance (%)
-1.62%
End price
19.03.26
€23.70
Summary
This prediction ended on 19.03.26 with a price of €23.70. With a performance of -1.62%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -4.262% | -4.262% | 6.474% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten